Nutritional composition for bariatric surgery patients
A composition, patient's technology, applied in the field of nutritional composition, able to solve the problems of clinical deficiency, reduced compliance, etc.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2011-05-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The present invention relates to nutritional compositions which are particularly suitable for use before and after bariatric surgery in morbidly obese patients. When used in patients on a calorie-restricted diet in the pre-bariatric surgery phase, the product helps reduce liver size and further helps maintain bone health and optimal nutritional needs in post-bariatric surgery patients .
[0002] The composition contains protein, digestible carbohydrates, dietary fiber, specific micronutrients, and preferably contains no or very low amounts of fat. Background technique
[0003] The rising rate of obesity is a major health problem affecting millions of people in the Western world. Bariatric surgical procedures including gastric bypass represent a successful way to achieve significant weight loss in morbidly obese individuals. After surgery, it is estimated that up to one third of patients suffer from nutritional deficiencies that cannot be overcome by...
Examples
Embodiment 1
[0082] This example describes a preferred nutritional composition in powder form for use in the treatment of bariatric surgery patients.
[0083]
[0084] 1 Lactose content is about 0.25%
[0085] 2 MD:MS is about 3.3:1
[0086] 3 For example Orafti (about 50% short chain fructooligosaccharides and 50% long chain inulin)
[0087] As stated, the total weight of the composition was 90.6 g. This represents the amount administered to the patient per day. The product is packaged as two sachets, each containing 45.3 g of the formulation. Mix each sachet with water to obtain a liquid product with a volume of 125-135 mL. The patient takes the liquid product two times a day.